Nevertheless, despite a very recent preliminary study, investigating clinical relevance of S100A4 protein in serum (Lv et al., 2018), this is the first study on MACC1 and S100A4 serum transcripts in ovarian cancer. This evidence concerns the gene S100A4 and ovarian carcinoma.